Respiri Extends US partnership with Access Telehealth
- Respiri (RSH) signs a second, five-year, non-exclusive distribution and marketing agreement with Access Telehealth in the United States
- Access is a premier provider of Remote Patient Monitoring (RPM) and telehealth services utilising their unique Remotl i platform
- The Access patient engagement business model is a strategic platform allowing Respir i to launch the high-value ‘wheezo’ Remote Asthma Monitoring Program (RAMP)
- The company continues to ramp up efforts and activities in the next critical phase of the US commercialisation pathway
- Shares in the company traded 3.85 per cent down at 5 cents at close of market on February 7
